China Resources Pharmaceutical Group Limited (3320.HK)
Makes and distributes pharmaceutical drugs, medicines, and healthcare products across China
4.90+0.01%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago-8.4%
The outlook
China Resources Pharmaceutical trades at 4.9, sitting well above both its 50- and 200-day moving averages, reflecting upward momentum. Analysts lean bullish with a consensus "Buy" rating, and their average price target sits roughly 39% above the current level. The stock trades near the lower end of its 52-week range at a modest 6.6 trailing P/E.
What’s behind the score
Analyst consensusBuy — 1.5 avg of 10 analysts
Price trendAbove its 50- & 200-day averages
52-week range29% of the way from its 52-week low to high
Price targetAvg target +39% vs current price
Analyst price target
~12-month · 10 analysts6.80average target+38.8% vs now
Now 4.90
Low 5.90High 7.52
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$30.78B
52-wk high
6.53
52-wk low
4.22
50-day avg
4.66
200-day avg
4.86
Trailing P/E
6.6